Nombramiento de Amie Mc Neice como vicepresidenta de marketing
Diaceutics appoints Amie Mc Neice as VP of Marketing
Belfast and London, 9 April 2024 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry, is pleased to announce the appointment of Amie Mc Neice as Vice President of Marketing. Amie previously held senior marketing and business development roles with Almac Group, Fibrus and Kingspan Plc.
Amie brings a wealth of marketing leadership experience to the team and will focus on delivering our 3-year marketing vision, brand positioning, messaging and integration of marketing automation. Amie has significant experience in working with US pharma customers.
Diaceutics is dedicated to scaling its sales and marketing capabilities in the US and Europe through 2024.
Diaceutics continues to invest in product development with the further expansion of its product management team in 2024. The product management team will deliver our product roadmap and co-ordinate our product activities across, data, scientific and medical services, engagement solutions, engineering and marketing.
Jillian Beggs, Chief Commercial Officer of Diaceutics, comentado: "I am delighted to welcome Amie to the team at Diaceutics. Our continued investment in sales and marketing supports our mission to provide the data, technology solutions and insights that enable our pharma and biotech customers revolutionise the commercialisation of their products and ultimately improve patient outcomes."
Amie Mc Neice, VP Marketing of Diaceutics comentado: "I have long admired Diaceutics and look forward to working with the team as we expand our sales and marketing capabilities and serve our customers' needs across the US and Europe."
Consultas:
PLC de diaceutica | |
Ryan Keeling, Director General Nick Roberts, director financiero
| Tel.: +44 (0) 28 9040 6500 |
Stifel Nicolaus Europe Limited (Nomad y Broker) | Tel.: +44 (0) 20 7710 7600 |
Ben Maddison, Nick Harland, Kate Hanshaw | |
Alma Comunicaciones Estratégicas | Tel: + 44 (0) 20 3405 0205 |
Caroline Forde, Kinvara Verdon, Kieran Breheny | |
Acerca de la diaceutica
En Diaceutics creemos que cada paciente debe tener la oportunidad de recibir la prueba y la terapia adecuadas para impactar positivamente el resultado de su enfermedad.
Proporcionamos a las principales empresas farmacéuticas y biotecnológicas del mundo una solución de comercialización de extremo a extremo para medicamentos de precisión a través de análisis de datos, servicios científicos y de asesoramiento habilitados por nuestra plataforma DXRX - The Diagnostics Network ®.
RNS puede usar su dirección IP para confirmar el cumplimiento de los términos y condiciones, para analizar cómo interactúa con la información contenida en esta comunicación y para compartir dicho análisis de forma anónima con otros como parte de nuestros servicios comerciales. Para obtener más información sobre cómo RNS y la Bolsa de Valores de Londres utilizan los datos personales que nos proporciona, consulte nuestra Política de privacidad.